Similar articles

• [Roferon-A (interferon alfa-2a) permitted for AIDS-associated Kaposi's sarcoma by the BGA].

  [No authors listed] [No authors listed] Immun Infekt. 1989 Feb;17(1):VIII. Immun Infekt. 1989. PMID: 2925218 German. No abstract available.
• [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].

  Lopez Bran E, Aguilar R, Marron JA, Figueredo MA, Garcia Ruiz JM. Lopez Bran E, et al. Med Cutan Ibero Lat Am. 1989;17(4):269-73. Med Cutan Ibero Lat Am. 1989. PMID: 2693866 Spanish.
• Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.

  Krigel RL, Slywotzky CM, Lonberg M, Green MD, Andes WA, Kempf R, Gupta S, Grace W, Spiegel RJ, Muggia FM, et al. Krigel RL, et al. J Biol Response Mod. 1988 Aug;7(4):359-64. J Biol Response Mod. 1988. PMID: 3049944 Clinical Trial.
• Biotherapy with interferon in AIDS-related Kaposi's sarcoma.

  Mitsuyasu RT, Miles SA. Mitsuyasu RT, et al. Oncol Nurs Forum. 1987 Nov-Dec;14(6 Suppl):27-31. Oncol Nurs Forum. 1987. PMID: 3320983 Review. No abstract available.
• Are there still indications for single agent high-dose interferon-alpha against AIDS-associated Kaposi's sarcoma?

  de Wit R. de Wit R. Int J STD AIDS. 1992 Mar-Apr;3(2):87-91. doi: 10.1177/095646249200300202. Int J STD AIDS. 1992. PMID: 1571393 Review. No abstract available.